{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:52:36Z","timestamp":1768488756975,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001632","name":"Ulster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001632","name":"Ulster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bbagen.2020.129811","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T17:45:53Z","timestamp":1607622353000},"page":"129811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice"],"prefix":"10.1016","volume":"1865","author":[{"given":"Shruti","family":"Mohan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aine M.","family":"McKillop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Charlotte","family":"Moffett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2020.129811_bb0005","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1755-5949.2010.00185.x","article-title":"Oxytocin: crossing the bridge between basic science and pharmacotherapy","volume":"16","author":"Viero","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbagen.2020.129811_bb0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/physrev.2001.81.2.629","article-title":"The oxytocin receptor system: structure, function, and regulation","volume":"81","author":"Gimpl","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbagen.2020.129811_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yfrne.2017.10.004","article-title":"Cross-talk among oxytocin and arginine-vasopressin receptors: relevance for basic and clinical studies of the brain and periphery","volume":"51","author":"Song","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cophys.2019.10.006","article-title":"Oxytocin and vasopressin signalling and myometrial contraction","volume":"13","author":"Arrowsmith","year":"2020","journal-title":"Curr. Opin. Physiol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.peptides.2017.12.019","article-title":"Oxytocin is present in islets and plays a role in beta-cell function and survival","volume":"100","author":"Mohan","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.bbagen.2020.129811_bb0030","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0196-9781(84)90109-8","article-title":"Modulation of insulin and glucagon secretion from the perfused rat pancreas by the neurohypophysial hormones and by desamino-D-arginine vasopressin (DDAVP)","volume":"5","author":"Dunning","year":"1984","journal-title":"Peptides"},{"key":"10.1016\/j.bbagen.2020.129811_bb0035","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1210\/jc.2014-2206","article-title":"Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients","volume":"99","author":"Qian","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbagen.2020.129811_bb0040","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.peptides.2017.11.014","article-title":"Role of islet peptides in beta cell regulation and type 2 diabetes therapy","volume":"100","author":"Khan","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.bbagen.2020.129811_bb0045","doi-asserted-by":"crossref","DOI":"10.1177\/1179551419888871","article-title":"Nonclassical islet peptides: pancreatic and extrapancreatic actions","volume":"12","author":"English","year":"2019","journal-title":"Clin. Med. Insights Endocrinol. Diabet."},{"key":"10.1016\/j.bbagen.2020.129811_bb0050","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2826.2012.02303.x","article-title":"Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics","volume":"24","author":"Manning","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0014-5793(69)80215-2","article-title":"Oxytocinase and its possible significance in the degradation of oxytocin during pregnancy","volume":"4","author":"Sj\u00f6holm","year":"1969","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2020.129811_bb0060","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0196-9781(91)90068-Z","article-title":"Proteolytic conversion of oxytocin by brain synaptic membranes: role of aminopeptidases and endopeptidases","volume":"12","author":"Stancampiano","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.bbagen.2020.129811_bb0065","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.bbagen.2013.03.011","article-title":"A novel acylated form of (d-Ala(2))GIP with improved antidiabetic potential, lacking effect on body fat stores","volume":"1830","author":"Martin","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2020.129811_bb0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/dom.13068","article-title":"Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice","volume":"20","author":"Parthsarathy","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbagen.2020.129811_bb0075","doi-asserted-by":"crossref","DOI":"10.1177\/1179551419855626","article-title":"Effects of 2 novel PYY(1-36) analogues, (P(3)L(31)P(34))PYY(1-36) and PYY(1-36)(Lys(12)PAL), on pancreatic beta-cell function, growth, and survival","volume":"12","author":"Lafferty","year":"2019","journal-title":"Clin. Med. Insights Endocrinol. Diabet."},{"key":"10.1016\/j.bbagen.2020.129811_bb0080","first-page":"129543","article-title":"Development and characterisation of a peptidergic N-and C-terminally stabilised mammalian NPY1R agonist which protects against diabetes induction","volume":"2020","author":"Lafferty","year":"1864","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2020.129811_bb0085","first-page":"265","article-title":"Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1\u221230) and GIP(1-42) in high-fat fed mice","volume":"208","author":"Gault","year":"2011","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0090","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2337\/diab.45.8.1132","article-title":"Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion","volume":"45","author":"McClenaghan","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.bbagen.2020.129811_bb0095","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","article-title":"Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice","volume":"20","author":"Flatt","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2020.129811_bb0100","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00125-014-3296-7","article-title":"A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation","volume":"57","author":"Lynch","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2020.129811_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bcp.2017.10.002","article-title":"Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties","volume":"146","author":"O\u2019Harte","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0110","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00125-016-4186-y","article-title":"An enzymatically stable GIP\/xenin hybrid peptide restores GIP sensitivity, enhances beta cell function and improves glucose homeostasis in high-fat-fed mice","volume":"60","author":"Hasib","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbagen.2020.129811_bb0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mce.2016.07.020","article-title":"Islet distribution of peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival","volume":"436","author":"Khan","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101005","article-title":"Role of endogenous GLP-1 and GIP in beta cell compensatory responses to insulin resistance and cellular stress","volume":"9","author":"Vasu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2020.129811_bb0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/hsz-2017-0136","article-title":"Locally produced xenin and the neurotensinergic system in pancreatic islet function and \u03b2-cell survival","volume":"399","author":"Khan","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbagen.2020.129811_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078560","article-title":"Alterations of glucose-dependent insulinotropic polypeptide and expression of genes involved in mammary gland and adipose tissue lipid metabolism during pregnancy and lactation","volume":"8","author":"Moffett","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2020.129811_bb0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.peptides.2017.12.004","article-title":"Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions","volume":"100","author":"O\u2019Harte","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.bbagen.2020.129811_bb0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biochi.2019.01.008","article-title":"Vasopressin receptors in islets enhance glucose tolerance, pancreatic beta-cell secretory function, proliferation and survival","volume":"158","author":"Mohan","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.bbagen.2020.129811_bb0145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1530\/eje.0.1310385","article-title":"Molecular characterization of a cloned human oxytocin receptor","volume":"131","author":"Kimura","year":"1994","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0150","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/jpet.113.202994","article-title":"Selective and potent agonists and antagonists for investigating the role of mouse oxytocin receptors","volume":"346","author":"Busnelli","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbagen.2020.129811_bb0155","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1210\/en.2009-0624","article-title":"Oxytocin increases glucose uptake in neonatal rat cardiomyocytes","volume":"151","author":"Florian","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbagen.2020.129811_bb0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1113\/jphysiol.2007.136481","article-title":"Insulin hypersensitivity in mice lacking the V1b vasopressin receptor","volume":"584","author":"Fujiwara","year":"2007","journal-title":"J. Physiol. Lond."},{"key":"10.1016\/j.bbagen.2020.129811_bb0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1152\/ajpendo.00269.2016","article-title":"Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V1A receptors","volume":"312","author":"Taveau","year":"2017","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"key":"10.1016\/j.bbagen.2020.129811_bb0170","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/ijo.2016.149","article-title":"Oxytocin\u2019s inhibitory effect on food intake is stronger in obese than normal-weight men","volume":"40","author":"Thienel","year":"2016","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bbagen.2020.129811_bb0175","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1113\/expphysiol.1989.sp003294","article-title":"Vasopressin reduces food intake in goats","volume":"74","author":"Meyer","year":"1989","journal-title":"Q. J. Exp. Physiol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0180","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1210\/js.2019-00004","article-title":"Long-acting and selective oxytocin peptide analogs show antidiabetic and antiobesity effects in male mice","volume":"3","author":"Snider","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.bbagen.2020.129811_bb0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pathophys.2012.07.005","article-title":"Pathophysiological function of oxytocin secreted by neuropeptides: a mini review","volume":"19","author":"Hashimoto","year":"2012","journal-title":"Pathophysiology"},{"key":"10.1016\/j.bbagen.2020.129811_bb0190","doi-asserted-by":"crossref","first-page":"350546","DOI":"10.1155\/2011\/350546","article-title":"The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents","volume":"2011","author":"Vrachnis","year":"2011","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0195","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1210\/en.2017-00557","article-title":"Central oxytocin and energy balance: more than feelings","volume":"158","author":"Gonz\u00e1lez-Garcia","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbagen.2020.129811_bb0200","doi-asserted-by":"crossref","first-page":"R447","DOI":"10.1152\/ajpregu.00520.2013","article-title":"Supraoptic oxytocin and vasopressin neurons function as glucose and metabolic sensors","volume":"306","author":"Song","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0205","doi-asserted-by":"crossref","first-page":"25185","DOI":"10.1038\/srep25185","article-title":"Oxytocin protects against stress-induced cell death in murine pancreatic \u00ce2-cells","volume":"6","author":"Watanabe","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2020.129811_bb0210","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1210\/en.2014-1466","article-title":"Divergent effects of oxytocin treatment of obese diabetic mice on adiposity and diabetes","volume":"155","author":"Altirriba","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbagen.2020.129811_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025565","article-title":"Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats","volume":"6","author":"Deblon","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2020.129811_bb0220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.physbeh.2018.08.007","article-title":"Intranasal oxytocin reduces weight gain in diet-induced obese prairie voles","volume":"196","author":"Seelke","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbagen.2020.129811_bb0225","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejphar.2008.11.043","article-title":"Altered lipid metabolism in vasopressin V1B receptor-deficient mice","volume":"602","author":"Hiroyama","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0230","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuropharm.2009.07.016","article-title":"Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist","volume":"58","author":"Ring","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbagen.2020.129811_bb0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/endrev\/bnz012","article-title":"Metabolic effects of oxytocin","volume":"41","author":"McCormack","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbagen.2020.129811_bb0240","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-020-02844-6","article-title":"Microneedle mediated transdermal delivery of protein, peptide and antibody based therapeutics: current status and future considerations","volume":"37","author":"Kirkby","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbagen.2020.129811_bb0245","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","article-title":"Advances in oral peptide therapeutics","volume":"19","author":"Drucker","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2020.129811_bb0250","doi-asserted-by":"crossref","first-page":"7883","DOI":"10.1038\/s41598-017-07949-4","article-title":"Intestinal transepithelial permeability of oxytocin into the blood is dependent on the receptor for advanced glycation end products in mice","volume":"7","author":"Higashida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2020.129811_bb0255","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1467-789X.2009.00581.x","article-title":"Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis","volume":"10","author":"Johansson","year":"2009","journal-title":"Obes. Rev."},{"key":"10.1016\/j.bbagen.2020.129811_bb0260","first-page":"175","article-title":"The neurobiology of love","volume":"26","author":"Esch","year":"2005","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.bbagen.2020.129811_bb0265","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fendo.2015.00081","article-title":"Oxytocin reverses osteoporosis in a sex-dependent manner","volume":"6","author":"Beranger","year":"2015","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbagen.2020.129811_bb0270","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbagen.2020.129811_bb0275","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/17446651.2015.1077697","article-title":"Effects of anti-diabetic drugs on bone metabolism","volume":"10","author":"Mabilleau","year":"2015","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"10.1016\/j.bbagen.2020.129811_bb0280","doi-asserted-by":"crossref","first-page":"170207","DOI":"10.1016\/j.peptides.2019.170207","article-title":"GIP analogues augment bone strength by modulating bone composition in diet-induced obesity in mice","volume":"125","author":"Vyavahare","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.bbagen.2020.129811_bb0285","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2337\/dc19-2237","article-title":"Lactation duration and long-term risk for incident type 2 diabetes in women with a history of gestational diabetes mellitus","volume":"43","author":"Ley","year":"2020","journal-title":"Diabetes Care"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416520303226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416520303226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:05:24Z","timestamp":1759637124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416520303226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0304416520303226"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2020.129811","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2020.129811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129811"}}